Trial intelligence / Profile preview

Intravenous immunoglobulins as early treatment in newly diagnosed idiopathic inflammatory myopathies (IMMEDIATE): a pilot study

2016-004766-26Phase 2Completed

Sponsor
Academic Medical Center
Start
Dec 2016
Countries
1
01

Overview

Phase 2, single-arm trial of polyvalent human immunoglobulin in Autoimmune Myopathies, sponsored by Academic Medical Center. Started Dec 2016; status: completed.

02

Drugs

polyvalent human immunoglobulin
03

Conditions

Autoimmune Myopathies

Beyond the preview

Go deeper on 2016-004766-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-004766-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call